Allergies affect an extensive number of individuals globally and their symptoms vary from mild to severe, which might manifest as sneezing, a runny nose, and itchy eyes. One of the most potent ...

In early August, the FDA approved neffy epinephrine nasal spray to treat emergent type 1 allergic reactions in patients who weigh at least 66 pounds. The approval was based on four studies of 175 ...

Recently in 2024, the agency received a report involving a patient who received the nasal solution as an injection.

The FDA has advised health care professionals that they should not use unapproved epinephrine nasal solutions manufactured by ...

Preliminary fourth quarter neffy® net product revenue of approximately $6.5 million Preliminary cash, cash equivalents and ...

For patients with allergic rhinitis, twice-daily azelastine plus fluticasone cut nasal symptoms ... all treatments were administered as one spray twice daily to preserve blinding.

According to Future Market Insights, the global nasal allergy treatment market is poised for substantial growth, with its valuation expected to double from USD 6.6 billion in 2022 to USD 13.3 billion ...

Dr. Scott Manthei of the Nevada Ear and Sinus Institute has been advising patients against taking drugs like Sudafed for ...

There are many unpleasant aspects of the cold winter season, and chief among them is the havoc it can wreak on sinuses. Even ...

Alongside over-the-counter NARCAN® Nasal Spray 4 mg, prescription KLOXXADO® (naloxone HCl) Nasal Spray 8 mg will expand Emergent’s ability to ...